Medical/Pharmaceuticals
Alphamab Oncology to Present Clinical Data of JSKN003 for the Treatment of HER2-expressing Solid Tumors at AACR 2024
SUZHOU, China, March 14, 2024 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced that data from phase I clinical study conducted inAustralia (JSKN003-101) of anti-HER2 bispecific antibody-drug conjugate (ADC) JSKN003 for the treatment of HER2-expressing advanced solid tumors, has b...
2024-03-14 08:39
2846
Pulsenmore is expanding the application of its home ultrasound solution for pregnant women: a clinical trial with Michigan Medicine will focus on the remote assessment of the fetal biophysical profile
RAMAT GAN, Israel, March 13, 2024 /PRNewswire/ -- Pulsenmore (TASE:PULS), the world leader in self-scan ultrasound technology for at-home use and remote clinical diagnosis, announces its new clinical study collaboration with Michigan Medicine. The study will examine the ability to conduct a remot...
2024-03-14 06:00
3779
Supply & Demand Chain Executive Honors TraceLink CEO Shabbir Dahod with Prestigious 2024 Pros to Know Lifetime Achievement Award
BOSTON, March 14, 2024 /PRNewswire/ -- In a well-deserved acknowledgment of a career dedicated to advancing the life sciences and healthcare supply chain sector, Supply & Demand Chain Executive has awarded Shabbir Dahod, President and Chief Executive Officer of TraceLink, a 2024 Pros to Know Life...
2024-03-14 04:15
6356
Nel ASA: Receives additional USD 75 million in support for Michigan facility
OSLO, Norway, March 14, 2024 /PRNewswire/ -- Nel ASA (Nel) (OSE: NEL) - The US Department of Energy (DOE) and the state ofMichigan have awarded a collective USD 75 million in cash incentives and grants for Nel's next electrolyser production facility inMichigan. "The support from the Department ...
2024-03-14 02:04
4110
Update on Lunit's Acquisition of Volpara: New Zealand High Court Initial Approval Secured
- Volpara shareholder meeting to be held on April 12, 2024: Culminating the acquisition journey for Lunit, finalization set for May SEOUL, South Korea, March 13, 2024 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, today ...
2024-03-13 21:00
2648
YolTech Therapeutics to Showcase Breakthroughs in in vivo Gene Editing at TIDES Asia 2024
SHANGHAI, March 13, 2024 /PRNewswire/ -- YolTech Therapeutics, a biotech
company pioneering inin vivo gene editing therapies, today announced
participation in TIDES Asia 2024, March 19th to 21st, 2024, at the Westin
Miyako Kyoto inKyoto, Japan.
TIDES Asia
2024-03-13 20:00
2176
Waters Advances Battery Electrode Design and Performance Analysis with New Rheo-IS Accessory
News Summary: * New Rheo-Impedance Spectroscopy (Rheo-IS) accessory enables battery scientists to better assess electrode slurry composition quality under real-world and process-relevant conditions. * The Rheo-IS accessory for TA Instruments Discovery™ Hybrid Rheometers employs a unique, pat...
2024-03-13 20:00
3283
Hummingbird Bioscience and Dartmouth's Geisel School of Medicine to Co-Host 3rd Annual Virtual VISTA Symposium on March 27, 2024
SINGAPORE and HANOVER, Germany, March 13, 2024 /PRNewswire/ -- Hummingbird Bioscience andDartmouth's Geisel School of Medicine today announced that the 3rd Annual VISTA Symposium will take place virtually onWednesday, March 27, 2024 ( 11:00 AM - 3:30 PM ET). VISTA is a novel immune checkpoint imp...
2024-03-13 17:00
3276
Sanyou Biopharmaceuticals Launches Advanced Intelligent R&D Service Platform
SHANGHAI, March 12, 2024 /PRNewswire/ -- Sanyou Biopharmaceutical Co., Ltd. is delighted to announce the official launch of the "Sanyou Intelligent Innovative Biologics R&D Service Platform," representing a transformative advancement in biopharmaceutical research and development. Our platform en...
2024-03-13 09:00
2103
Novel Molecules From Generative AI to Phase II: First Novel TNIK Inhibitors for Fibrotic Diseases Discovered and Designed Using Generative AI
* A study published in Nature Biotechnology presents the entire journey of INS018_055, from AI algorithms to Phase II clinical trials for the first time. * Raw data from 13 preclinical experiments and 3 clinical trials referenced in this study can be accessed by visiting Insilico'sdata room <...
2024-03-13 08:00
3772
IGEL Teams with Insentra and Insight to Help Western Health Improve Endpoint Management and Sustainability, Boost Security, and Enhance User Experience
IGEL's integration with Imprivata makes it easy for the Australian healthcare provider to securely access Cerner's electronic medical records (EMR) software and extend the life of legacy endpoint devices SAN FRANCISCO and SYDNEY, March 12, 2024 /PRNewswire/ -- Western Health, one ofAustralia's l...
2024-03-13 04:00
2775
AITRICS to Participate in HIMSS USA 2024
- Three consecutive years of participation in HIMSS USA - Showcasing 'VitalCare' which is an AI Solution for Predicting Patient Deterioration. SEOUL, South Korea, March 12, 2024 /PRNewswire/ -- AITRICS (CEO Kwang joon Kim), a company specializing in medical artificial intelligence (AI) technology...
2024-03-12 22:50
2422
Datasea to Drive Growth in its Acoustic Business via Product Upgrades and U.S. Market Entry
BEIJING, March 12, 2024 /PRNewswire/ -- Datasea Inc. (NASDAQ: DTSS) ("Datasea" or the "Company"), aNevada corporation engaged in innovative business segments for Acoustics Hi-tech and 5G-AI multimodal communication technology inChina and the U.S., announced today its latest plan for the Company's...
2024-03-12 22:40
4318
Mabwell to Present Pre-clinical Results at the 2024 American Association for Cancer Research (AACR) Annual Meeting
SHANGHAI, March 12, 2024 /PRNewswire/ -- Mabwell (688062.SH), an innovation-driven biopharmaceutical company with entire industry chain, announced that it will present results of three preclinical studies as poster presentation at the AACR Annual Meeting to be held inSan Diego, USA, from April 5...
2024-03-12 22:00
2539
Zhongchao Inc. Announces Successful Medication Assistance Services for Over 7,000 SLE Patients with Approximately 130,000 Units of Medications
SHANGHAI, March 12, 2024 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services for patients with cancer and other major diseases, today announced that Shanghai Zhongxin Medical Technology Co., Ltd. ("Zhongxin")...
2024-03-12 20:30
3804
Metabolon and Cardiff University Centre for Neuropsychiatric Genetics and Genomics Forge Alliance to Propel Multiple Sclerosis Research
Partnership will investigate the underlying disease mechanisms of multiple sclerosis (MS) with the potential of finding new relevant drug targets MORRISVILLE, N.C., March 12, 2024 /PRNewswire/ -- Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of li...
2024-03-12 20:05
2349
Longbio Pharma Presented Positive Phase 1 Results for LP-003 at 2024AAD
SAN DIEGO, March 12, 2024 /PRNewswire/ -- Longbio Pharma (Suzhou) Co., Ltd. (referred to as "Longbio Pharma"), a leading biotech company dedicated to developing innovative protein treatments for allergy, respiratory, dermatology, hematology, ophthalmology, and other autoimmune and rare diseases, ...
2024-03-12 20:00
2494
Ajinomoto Bio-Pharma Services Garners Six 'CDMO Leadership Awards,' Further Establishing Its Industry Excellence
SAN DIEGO and TOKYO and WETTEREN, Belgium, March 12, 2024 /PRNewswire/ -- Ajinomoto Bio-Pharma Services ("Aji Bio-Pharma"), a leading provider of biopharmaceutical contract development and manufacturing services, received CDMO Leadership Awards in all six categories - Capabilities, Compatibility,...
2024-03-12 20:00
2669
Baird Medical and ExcelFin Acquisition Corp Announce Strategic Update to Business Combination Terms to Reinforce Long-Term Value Creation Opportunity and Alignment with Shareholders
* Baird Medical agreed to subject 30% of its shares to be received in the transaction to an earnout at a$12.50 trading price * Minimum cash condition of $15 million has been waived, cementing certainty and expediency to our transaction close * Upon closing, Baird Medical is expected to trade...
2024-03-12 19:00
3046
Innovating the Future: ISoOR 2024 Annual Meeting Achieves Remarkable Success
SINGAPORE, March 12, 2024 /PRNewswire/ -- From March 7 to 8, 2024, the International Society of Organoid Research (ISoOR) convened its 2024 annual meeting, after the successful conference inSingapore last year. This year, the conference was held in the vibrant city ofShanghai, China, reflecting t...
2024-03-12 11:57
2761
Week's Top Stories
Most Reposted
UFO SIM Launches in Australia, The Ultimate Travel eSIM Starting at Just AU$2/GB
[Picked up by 310 media titles]
2026-04-01 11:03
Sustainable Tourism Impact Fund Expands Investments Across Southeast Asia
[Picked up by 309 media titles]
2026-04-03 11:30
Surfin Meta Digital Technology signs MOU with the Philippine Social Security System to explore digital financial service enhancements
[Picked up by 307 media titles]
2026-04-01 09:00
From Doomscroll to Page-Turner: BookXcess Launches The Brain Un-Rot Library to Help Rebuild a Generation's Focus
[Picked up by 302 media titles]
2026-03-31 13:53
Visa cements global K-pop connection as Worldwide Tour Sponsor for "BTS WORLD TOUR 'ARIRANG'"
[Picked up by 300 media titles]
2026-04-06 10:00
Most Read
NYSE Content Update: Versigent To Ring Opening Bell As its Shares Debut for Trade
2026-04-01 22:44
5711
